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Despite improvements to intensive care management and speciﬁ c pharmacological treatments (atropine, 
oxime, diazepam), the mortality associated with organophosphate (OP) poisoning has not substantially 
decreased. The objective of this examination was to describe the role of fresh frozen plasma (FFP) in acute 
OP poisoning. After a deliberate ingestion of malathion, a 55-year-old male suffering from miosis, 
somnolence, bradycardia, muscular fasciculations, rales on auscultation, respiratory insufﬁ ciency, as well 
as from an inhibition of red blood cell acetylcholinesterase (AChE) and plasma butyrylcholinesterase 
(BuChE), was admitted to hospital. Malathion was conﬁ rmed in a concentration of 18.01 mg L-1. Apart 
from supportive measures (including mechanical ventilation for four days), antidotal treatment with atropine, 
oxime - pralidoxime methylsulphate (Contrathion®), and diazepam was administered, along with FFP. The 
potentially beneﬁ cial effects of FFP therapy included a prompt increase of BuChE activity (from 926 IU L-1 
to 3277 IU L-1; reference range from 7000 IU L-1 to 19000 IU L-1) and a reduction in the malathion 
concentration, followed by clinical recovery. Due to BuChE replacement, albumin content, and volume 
restitution, FFP treatment may be used as an alternative approach in patients with acute OP poisoning, 
especially when oximes are not available.
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The conventional approach to organophosphate 
(OP) poisoning treatment involves efforts to counteract 
the effects of excessive acetylcholine (ACh) 
accumulation and the overstimulation of cholinergic 
neurons caused by irreversible acetylcholinesterase 
(AChE) inhibition. Atropine effectively reduces 
muscarinic signs, while oximes reactivate inhibited 
AChE and directly detoxify unbound OPs (1). Despite 
the use of these antidotes and improvements to 
intensive care, the mortality associated with OP 
poisoning remains high and calls for new alternative 
treatments (2, 3). Fresh frozen plasma (FFP) or 
albumin, acting as a bioscavenger to clean up 
circulatory OPs, has been evaluated as an alternative 
treatment modality, but the few studies that have 
investigated it are controversial and need to be clariﬁ ed 
(4, 5).
SUBJECTS AND METHODS
A 55-year-old farmer was brought to the National 
Poison Control Centre with miosis and an organic 
solvent-like odour. The patient complained of nausea, 
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vomiting, and diarrhoea, but his vital signs were 
normal: blood pressure 140 mm Hg /70 mm Hg, pulse 
70 bpm, oxygen saturation (sO2) 96 %. Three hours 
earlier, he drank 100 mL of pesticide formula, 
containing 600 g L-1 of malathion. A gastric lavage 
was performed, followed by an administration of 50 g 
of activated charcoal and an evacuation of white 
coloured solution. After admission to the Intensive 
Care Unit 4 h after ingestion, he was somnolent, 
spontaneously breathing, with copious bronchial 
secretion, pinpoint pupils, muscle fasciculations, 
hypotension (90 mm Hg /70 mm Hg), pulse 90 bpm, 
and had a respiratory rate of 25 min-1. Apart from 
supportive measures, he received 12 mg of atropine 
during the ﬁ rst 30 min, followed by a continuous 
infusion of atropine. The patient was administered 2 g 
of pralidoxime methylsulphate as a loading dose, 
followed by 500 mg h-1 in a continuous infusion and 
fresh frozen plasma (two bags, from 220 mL to 
250 mL every 12 h for 2 days; total of 8 bags). Due 
to the development of respiratory insufficiency 
[pH 7.54, pO2 50, s O2 89 %, pCO2 32, actual base 
excess (ABE) 4.9] and copious bronchial secretion, 
the patient was intubated and mechanical ventilation 
was initiated. Routine laboratory tests were within 
normal limits. 
RESULTS
Initially, the number of red blood cell (RBC) AChE 
and plasma BuChE showed an activity of 1862 IU L-1 
(reference range from 4000 IU L-1 to 8000 IU L-1) and 
926 IU L-1 (reference range from 7000 IU L-1 to 
19000 IU L-1), respectively, with a significant 
reduction of AChE activity to 903 IU L-1 and an 
increase of BuChE to 3227 IU L-1 after 6 h (and the 
first dose of fresh frozen plasma). On day one, 
malathion was conﬁ rmed in the blood by the liquid 
chromatography-mass spectrometry method (LC-MS) 
at a concentration of 18.01 mg L-1. After 5 h, the 
concentration of malathion was 11.25 mg L-1, and after 
the second dose of plasma, the level of malathion was 
1.21 mg L-1. After the third dose of FFP, malathion 
concentrations reduced even further (0.07 mg L-1 and 
0.02 mg L-1), while on day two, it was no longer 
detected.  Mean  BuChE level  of  FFP was 
(10868±1078) IU L-1, while the total albumin given 
amounted to 82 g.
AChE activity continued to decrease, whereas 
BuChE responded well to FFP therapy (from 926 
IU L-1, the level increased to 1576 U L-1 after the ﬁ rst, 
and from 3227 IU L-1 to 5816 IU L-1 after the second 
dose) (Figure 1).
Figure 1 BuChE and AChE activity ±SD, with the malathion concentration ±SD in blood 
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In order to evaluate the capacity of FFP for binding 
malathion to albumin (mean value 4.1 g L-1), a water 
solution of insecticide was incubated in vitro with FFP 
in a molar ratio 1:1 of its albumin content. The mixture 
was kept in a water bath at 37 °C for various time 
intervals ranging from 1 h to 24 h. The unbound 
malathion concentration was determined by the LC-
MS method. The results showed that malathion was 
bound to FFP at a concentration of 200.8 mg L-1, with 
a t1/2 of 2.1 h.
The clinical recovery was gradual. Mechanical 
ventilation was no longer necessary from day four, 
and only small daily doses of atropine were needed. 
The total atropine dose was 735 mg, and pralidoxime 
was used for four days. The patient’s condition 
improved steadily and he was discharged from the 
hospital on day seven.
DISCUSSION
Butyrylcholinesterase functions as a natural 
bioscavenger that binds OPs stoichiometrically and 
thus inactivates them. The advantage of the prophylactic 
use of purified human BuChE was confirmed in 
various OPs, including soman, sarin, and tabun. A 
single dose of BuChE was able to maintain therapeutic 
concentrations for at least four days, protecting 
humans from an exposure of 2 x LD50 to 5 x LD50 (3, 
6). An experimental study on guinea pigs conﬁ rmed 
that the nerve agents sarin, soman, cyclosarin, and 
tabun formed phosphorylated adducts with a tyrosine 
residue on albumin when incubated with human 
plasma in vitro. Albumin served as a relatively long-
lived biological marker not only for nerve agents (7), 
but also for dichlorvos (8).
No human trials involving BuChE have been 
conducted due to the high costs and large quantity 
needed for the inactivation of OPs. An alternative 
approach would be to use FFP. In a prospective clinical 
study, Güven et al. (4) applied FFP with atropine and 
pralidoxime in 12 patients with OP poisoning, while 
22 patients were given atropine and oximes (controls). 
In the control group, the mortality was 14.3 %, and 
intermediate syndrome (IMS) was 28.6 %, while 
neither lethal outcomes nor IMS were registered in 
the group with FFP. Furthermore, plasmapheresis with 
FFP was used on a patient with fenitrothion poisoning 
who developed sepsis. After plasma exchange therapy, 
ChE levels increased and the patient’s clinical 
condition resulted in a complete recovery (9).
Contrary to this, the results of an open-labelled 
pilot randomized trial involving the comparison of 
FFP, albumin, and saline in sixty patients with acute 
OP poisoning did not show any favourable effects on 
the clinical outcomes (5). Despite a signiﬁ cant increase 
in BuChE levels with FFP, a greater number of IMS 
cases were observed, and there were no differences in 
atropine requirement, duration of mechanical 
ventilation, hospital stay or mortality. Two explanations 
for the unsuccessful treatment were offered: ageing 
of OP-ChE and OP-albumin complex dissociation 
(7).
Fulton (10) attempted to explain the favourable 
effect of FFP found by Güven et al. (4, 9) through 
discussing “the secret ingredient” and suggested that 
aggressive volume resuscitation with BuChE serves 
as a possible scavenger; however, the author did not 
comment on the same presumed role of albumin.
Our patient was severely poisoned by malathion, 
with pronounced muscarinic and nicotinic effects and 
a marked inhibition of AChE and BuChE. The 
malathion concentration in the patient’s blood was 
18.01 mg L-1, which was reduced rapidly by an 
administration of FFP. This concentration is close to 
the malathion blood level of 23.9 mg L-1 found 
antemortem in a suicidal poisoning (11). Malathion is 
a dimethyl-organophosphate with a low toxicity in 
humans. However, many fatal human ingestions of 
malathion have been documented in the literature, 
with the lethal doses estimated to range from 
350 mg kg-1 to 1000 mg kg-1 (12). In addition to 
atropine, oximes, and supportive measures, FFP was 
administered during two days. A prompt increase of 
BuChE activity and volume restitution containing 
albumin eliminated the poison. This was followed by 
a clinical recovery, which was ascribed to the 
beneﬁ cial effects of FFP therapy, primarily induced 
by supplemented BuChE and albumin.
CONCLUSION
The patient with severe malathion poisoning was 
successfully treated by atropine, oximes, and FFP. The 
potentially beneﬁ cial effects of FFP are an increase of 
BuChE activity, colloid volume replacement, and rapid 
elimination of OPs. We believe that FFP may have 
helped in this case and that it could be used as a 
supplement in acute OP poisonings, especially when 
oximes are not available.
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Sažetak
SVJEŽA SMRZNUTA PLAZMA KAO UČINKOVIT DODATAK ANTIDOTSKOJ TERAPIJI U 
SLUČAJU AKUTNOG OTROVANJA ORGANOFOSFATOM
Unatoč napretku intenzivnog liječenja i speciﬁ čne farmakološke terapije (atropin, oksim, diazepam), 
mortalitet u akutnim trovanjima organofosfatima (engl. Organophosphate, OP) nije se značajno smanjio. 
Cilj je bio upozoriti na ulogu svježe smrznute plazme (engl. Fresh frozen plasma, FFP) u liječenju akutnih 
otrovanja OP-ima. Nakon namjerne ingestije malationa, u bolnicu je primljen muškarac u dobi od 55 
godina s miozom, somnolencijom, bradikardijom, mišićnim fascikulacijama, pukotima pri auskultaciji 
pluća i respiratornom insuﬁ cijencijom kao karakterističnim znacima trovanja organofosfatom, kao i 
inihibicijom eritrocitne acetilkolinesteraze (AChE) i plazmatske butirilkolinesteraze (BuChE). U krvi je 
potvrđena prisutnost malationa u koncentraciji od 18,01 mg L-1. Pored pratećih mjera (uključujući 
mehaničku ventilaciju tijekom četiri dana), primijenjena je antidotska terapija atropinom, oksimom 
pralidoksim-metilsulfatom (Contrathion®) i diazepamom, zajedno s FFP-om. Naglo povećanje aktivnosti 
BuChE (od 926 IU L-1 do 3277 IU L-1; referentna vrijednost od 7000 IU L-1 do 19000 IU L-1), eliminacija 
otrova s promptnom redukcijom koncentracije malationa, uz klinički oporavak, mogu se pripisati povoljnim 
učincima terapije FFP-om kao adjuvansom. FFP osigurava BuChE, povećani sadržaj albumina i nadoknadu 
volumena, zbog čega se može koristiti kao alternativni način liječenja akutnih trovanja OP-ima, posebno 
kada nam nisu dostupni oksimi.
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